{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:35:32Z","timestamp":1790778932084,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic caused hospital pressures resulting in some patients with severe COVID-19 not being admitted. Studies aiming to measure treatment effects in patients with severe COVID-19 might produce biased estimates if restricted to hospitalised cohorts as a subset of the target population remained unobserved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To quantify the effects of potential selection bias due to deaths outside of hospital in a case study of inhaled corticosteroids (ICS) and COVID-19 death among people with chronic obstructive pulmonary disease (COPD) hospitalised with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using Clinical Practice Research Datalink Aurum linked to hospitalisation and death registries, we defined a cohort with COPD on 01 Mar 2020, followed up until 31st August 2020. We assessed the odds of COVID-19 death (International Classification of Diseases, 10th Revision U07) among hospitalised COVID-19 patients, comparing current users of ICS\/long-acting \u03b2-agonist (LABA) and LABA\/long-acting muscarinic antagonist (LAMA)). Our target population was those with COPD and severe COVID-19. We evaluated potential selection bias due to non-admission of severe COVID-19 cases using quantitative bias analysis (QBA) in four plausible scenarios, varying assumed death rates among non-hospitalised patients. Selection probabilities for deaths due to COVID-19 were known. The assumptions were: (1) equal odds of death between non-hospitalised and hospitalised groups; (2) doubled odds of death in non-hospitalised ICS\/LABA group compared to hospitalised; (3) halved odds of death in non-hospitalised ICS\/LABA group; and (4) doubled odds of death in both treatment groups among non-hospitalised patients. We calculated bootstrapped 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 107 ICS\/LABA users and 133 LABA\/LAMA users were hospitalised with COVID-19. COVID-19 deaths occurred in 42 (39.3%) ICS\/LABA users versus 50 (37.6%) LABA\/LAMA users. The OR after inverse probability of treatment weighting was 1.01 (95% CI 0.59\u20131.72). In scenario 1, the OR was unchanged (OR 1.07, 95% CI 0.70\u20131.67). In scenario 2, the corrected OR was 1.28 (95% CI 0.83\u20132.00). In scenario 3, the corrected OR was 0.81 (95% CI 0.52\u20131.23). In scenario 4, the corrected OR was 1.08 (95% CI 0.69\u20131.71).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>QBA facilitated an assessment of the sensitivity of study results to potential selection bias due to non-admission of a subset of patients with severe COVID-19. The results of the four scenarios presented are in line with the null hypothesis, but CIs were wide. Death rates in the non-hospitalised would have needed to be substantially different in the treatment groups to change the study conclusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12874-025-02732-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:34:30Z","timestamp":1768534470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantifying selection bias due to unobserved patients in pharmacoepidemiologic studies of severe COVID-19 cohorts"],"prefix":"10.1186","volume":"26","author":[{"given":"Marleen","family":"Bokern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2732_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21220-5","volume":"12","author":"RG Jung","year":"2021","unstructured":"Jung RG, Santo PD, Clifford C, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12:1\u201310. https:\/\/doi.org\/10.1038\/s41467-021-21220-5.","journal-title":"Nat Commun"},{"key":"2732_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/PDS.5029","volume":"29","author":"A Potteg\u00e5rd","year":"2020","unstructured":"Potteg\u00e5rd A, Kurz X, Moore N, Christiansen CF, Klungel O. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiol Drug Saf. 2020;29:825\u201331. https:\/\/doi.org\/10.1002\/PDS.5029.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2732_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","volume":"9","author":"CI Bloom","year":"2021","unstructured":"Bloom CI, Drake TM, Docherty AB, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO clinical characterisation protocol UK. Lancet Respir Med. 2021;9:699\u2013711. https:\/\/doi.org\/10.1016\/S2213-2600(21)00013-8.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"2732_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5345","volume":"30","author":"A Husby","year":"2021","unstructured":"Husby A, Potteg\u00e5rd A, Hviid A. Association between inhaled corticosteroid use and COVID-19 outcomes. Pharmacoepidemiol Drug Saf. 2021;pds.5345. https:\/\/doi.org\/10.1002\/pds.5345.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2732_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2020.102567","volume":"19","author":"Y Jamilloux","year":"2020","unstructured":"Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19:102567. https:\/\/doi.org\/10.1016\/J.AUTREV.2020.102567.","journal-title":"Autoimmun Rev"},{"key":"2732_CR6","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1038\/s41467-020-19478-2","volume":"11","author":"GJ Griffith","year":"2020","unstructured":"Griffith GJ, Morris TT, Tudball MJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11:5749. https:\/\/doi.org\/10.1038\/s41467-020-19478-2.","journal-title":"Nat Commun"},{"key":"2732_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-82673-4","volume-title":"Applying quantitative bias analysis to epidemiologic data","author":"MP Fox","year":"2021","unstructured":"Fox MP, MacLehose RF, Lash TL. Applying quantitative bias analysis to epidemiologic data. Cham: Springer International Publishing; 2021. https:\/\/doi.org\/10.1007\/978-3-030-82673-4."},{"key":"2732_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/pds.4076","volume":"25","author":"JN Hunnicutt","year":"2016","unstructured":"Hunnicutt JN, Ulbricht CM, Chrysanthopoulou SA, Lapane KL. Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review. Pharmacoepidemiol Drug Saf. 2016;25:1343\u201353. https:\/\/doi.org\/10.1002\/pds.4076.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2732_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/ije\/dyab061","volume":"50","author":"JM Petersen","year":"2021","unstructured":"Petersen JM, Ranker LR, Barnard-Mayers R, MacLehose RF, Fox MP. A systematic review of quantitative bias analysis applied to epidemiological research. Int J Epidemiol. 2021;50:1708\u201330. https:\/\/doi.org\/10.1093\/ije\/dyab061.","journal-title":"Int J Epidemiol"},{"key":"2732_CR10","unstructured":"Edge Health. The hospitals facing most pressure to meet coronavirus demand. 2020. Available at: https:\/\/www.edgehealth.co.uk\/news-insights\/the-hospitals-facing-most-pressure-to-meet-coronavirus-demand\/. Accessed 25 May 2025."},{"key":"2732_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12916-020-01781-w","volume":"18","author":"R McCabe","year":"2020","unstructured":"McCabe R, Schmit N, Christen P, et al. Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Med. 2020;18:329. https:\/\/doi.org\/10.1186\/s12916-020-01781-w.","journal-title":"BMC Med"},{"key":"2732_CR12","unstructured":"Deaths registered weekly in England and Wales, provisional - Office for National Statistics. Available at: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/datasets\/weeklyprovisionalfiguresondeathsregisteredinenglandandwales. Accessed 5 Oct 2022."},{"key":"2732_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70086","volume":"34","author":"M Bokern","year":"2025","unstructured":"Bokern M, Rentsch CT, Quint JK, Hunnicutt J, Douglas I, Schultze A. Using quantitative bias analysis to adjust for misclassification of COVID-19 outcomes: an applied example of inhaled corticosteroids and COVID-19 outcomes. Pharmacoepidemiol Drug Saf. 2025;34:e70086. https:\/\/doi.org\/10.1002\/pds.70086.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2732_CR14","doi-asserted-by":"publisher","unstructured":"Clinical Practice Research Datalink. Release Notes: CPRD Aurum March 2022. 2022. https:\/\/doi.org\/10.48329\/my9s-4x08","DOI":"10.48329\/my9s-4x08"},{"key":"2732_CR15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/IJE\/DYZ034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf A, Dedman D, Campbell J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48:1740\u20131740g. https:\/\/doi.org\/10.1093\/IJE\/DYZ034.","journal-title":"Int J Epidemiol"},{"key":"2732_CR16","unstructured":"Hospital Episode Statistics (HES) Admitted Patient Care and CPRD primary care data Documentation (set 21). 2021. Available at: https:\/\/www.cprd.com\/sites\/default\/files\/2022-02\/Documentation_HES_OP_set21.pdf. Accessed 9 Dec 2021."},{"key":"2732_CR17","unstructured":"ONS death registration data. and CPRD primary care data Documentation (set 21) Version 2.5. 2021."},{"key":"2732_CR18","unstructured":"Clinical Practice Research Datalink. CPRD linked data | CPRD. Available at: https:\/\/www.cprd.com\/linked-data#HES%20Admitted%20Patient%20Care%20data. Accessed 9 Dec 2021."},{"key":"2732_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2014-005540","volume":"4","author":"JK Quint","year":"2014","unstructured":"Quint JK, M\u00fcllerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014;4:e005540. https:\/\/doi.org\/10.1136\/BMJOPEN-2014-005540.","journal-title":"BMJ Open"},{"key":"2732_CR20","unstructured":"National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2018. Available at: www.nice.org.uk\/guidance\/ng115. Accessed 12 Oct 2021."},{"key":"2732_CR21","doi-asserted-by":"publisher","unstructured":"Schneeweiss S, Rassen JA, Brown JS et al. Graphical depiction of longitudinal study designs in health care databases. 2019. https:\/\/doi.org\/10.7326\/M18-3079","DOI":"10.7326\/M18-3079"},{"key":"2732_CR22","doi-asserted-by":"publisher","first-page":"e0151357","DOI":"10.1371\/JOURNAL.PONE.0151357","volume":"11","author":"KJ Rothnie","year":"2016","unstructured":"Rothnie KJ, M\u00fcllerov\u00e1 H, Hurst JR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One. 2016;11:e0151357. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0151357.","journal-title":"PLoS One"},{"key":"2732_CR23","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. https:\/\/doi.org\/10.1136\/bmj.b2393.","journal-title":"BMJ"},{"key":"2732_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12963-023-00302-0","volume":"21","author":"SI Shiekh","year":"2023","unstructured":"Shiekh SI, Harley M, Ghosh RE, et al. Completeness, agreement, and representativeness of ethnicity recording in the united kingdom\u2019s clinical practice research datalink (CPRD) and linked hospital episode statistics (HES). Popul Health Metrics. 2023;21:3. https:\/\/doi.org\/10.1186\/s12963-023-00302-0.","journal-title":"Popul Health Metrics"},{"key":"2732_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/1475-6773.12182","volume":"49","author":"MM Garrido","year":"2014","unstructured":"Garrido MM, Kelley AS, Paris J, et al. Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49:1701\u201320. https:\/\/doi.org\/10.1111\/1475-6773.12182.","journal-title":"Health Serv Res"},{"key":"2732_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/EDE.0b013e31823b6296","volume":"23","author":"D Westreich","year":"2012","unstructured":"Westreich D. Berkson\u2019s bias, selection bias, and missing data. Epidemiology. 2012;23:159\u201364. https:\/\/doi.org\/10.1097\/EDE.0b013e31823b6296.","journal-title":"Epidemiology"},{"key":"2732_CR27","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","volume":"376","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376:2245\u201354. https:\/\/doi.org\/10.1056\/NEJMoa1612222.","journal-title":"N Engl J Med"},{"key":"2732_CR28","volume-title":"Stata Statistical Software: Release 17 College Station","author":"StataCorp","year":"2021","unstructured":"StataCorp. Stata Statistical Software: Release 17 College Station. StataCorp LLC; 2021."},{"key":"2732_CR29","unstructured":"Team RCR. A language and environment for statistical computing. R Foundation for Statistical Computing. 2025. Available at: https:\/\/www.R-project.org\/"},{"key":"2732_CR30","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","volume":"370","author":"KF Huybrechts","year":"2014","unstructured":"Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370:2397\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1312828.","journal-title":"N Engl J Med"},{"key":"2732_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1035","author":"BT Bateman","year":"2015","unstructured":"Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: cohort study. BMJ. 2015. https:\/\/doi.org\/10.1136\/bmj.h1035.","journal-title":"BMJ"},{"key":"2732_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100936","volume":"37","author":"LA Thompson","year":"2021","unstructured":"Thompson LA, Gurka MJ, Filipp SL, et al. The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection. EClinicalMedicine. 2021;37:100936. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100936.","journal-title":"EClinicalMedicine"},{"key":"2732_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/EDE.0000000000001032","volume":"30","author":"LH Smith","year":"2019","unstructured":"Smith LH, Vanderweele TJ. Bounding bias due to selection. Epidemiology. 2019;30:509\u201316. https:\/\/doi.org\/10.1097\/EDE.0000000000001032.","journal-title":"Epidemiology"},{"key":"2732_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund JL, Richardson DB, St\u00fcrmer T. The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep. 2015;2:221\u20138. https:\/\/doi.org\/10.1007\/s40471-015-0053-5.","journal-title":"Curr Epidemiol Rep"},{"key":"2732_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02112-2018","author":"S Suissa","year":"2019","unstructured":"Suissa S. Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias? Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.02112-2018.","journal-title":"Eur Respir J"},{"key":"2732_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad173","volume":"52","author":"C Brack","year":"2023","unstructured":"Brack C, Kynn M, Murchie P, Makin S. Validated frailty measures using electronic primary care records: a review of diagnostic test accuracy. Age Ageing. 2023;52:afad173. https:\/\/doi.org\/10.1093\/ageing\/afad173.","journal-title":"Age Ageing"},{"key":"2732_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100295","volume":"14","author":"A Schultze","year":"2022","unstructured":"Schultze A, Nightingale E, Evans D, et al. Mortality among care home residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3\u00a0million adults over the age of 65. The Lancet Regional Health - Europe. 2022;14:100295. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100295.","journal-title":"The Lancet Regional Health - Europe"},{"key":"2732_CR38","unstructured":"Covid. What happened to care homes early in the pandemic? BBC News. https:\/\/www.bbc.com\/news\/52674073. Published May 18, 2020. Accessed 19 Nov 2024."},{"key":"2732_CR39","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/QAD.0000000000003314","volume":"36","author":"G LI","year":"2022","unstructured":"LI G, PARK LS. Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV. AIDS. 2022;36:1689\u201396. https:\/\/doi.org\/10.1097\/QAD.0000000000003314.","journal-title":"AIDS"},{"key":"2732_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/EDE.0000000000000013","volume":"25","author":"MM Glymour","year":"2014","unstructured":"Glymour MM, Vittinghoff E, Commentary. Selection bias as an explanation for the obesity paradox: just because it\u2019s possible doesn\u2019t mean it\u2019s plausible. Epidemiology. 2014;25:4. https:\/\/doi.org\/10.1097\/EDE.0000000000000013.","journal-title":"Epidemiology"},{"key":"2732_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S2213-2600(21)00547-6","volume":"10","author":"J Crook","year":"2022","unstructured":"Crook J, Weinman J, Gupta A. Changes in rates of prescriptions for inhaled corticosteroids during the COVID-19 pandemic. Lancet Respir Med. 2022;10:6. https:\/\/doi.org\/10.1016\/S2213-2600(21)00547-6.","journal-title":"Lancet Respir Med"},{"key":"2732_CR42","unstructured":"NHS Digital. Appointments in General Practice May 2020. 2020. Available at: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/appointments-in-general-practice\/may-2020. Accessed 7 Dec 2021."},{"key":"2732_CR43","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/ije\/25.6.1107","volume":"25","author":"S Greenland","year":"1996","unstructured":"Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol. 1996;25:1107\u201316. https:\/\/doi.org\/10.1093\/ije\/25.6.1107.","journal-title":"Int J Epidemiol"},{"key":"2732_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/EDE.0000000000001516","volume":"33","author":"H Lu","year":"2022","unstructured":"Lu H, Cole SR, Howe CJ, Westreich D. Toward a clearer definition of selection bias when estimating causal effects. Epidemiology. 2022;33:699\u2013706. https:\/\/doi.org\/10.1097\/EDE.0000000000001516.","journal-title":"Epidemiology"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02732-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:47:12Z","timestamp":1781628432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12874-025-02732-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2732"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02732-w","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by the London School of Hygiene and Tropical Medicine Research Ethics Committee (Reference: 27896) and the Independent Scientific Advisory Committee of the UK Medicines and Healthcare Products Regulatory Agency (Approval Number: 22_001876).Under CPRD\u2019s ethical approval from the UK Health Research Authority to support research using anonymised patient data, individual patient consent is not required. Individuals registered with participating GP practices are included in the CPRD dataset unless they opt out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB is funded by a GSK PhD studentship to investigate the application of quantitative bias analysis in observational studies of COVID-19. ID has unrestricted grants from and shares in GSK. AS is employed by LSHTM on a fellowship funded by GSK. CTR and JQ report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}